Cite
APA Citation
Cicènas, S., Geater, S. L., Petrov, P., Hotko, Y., Hooper, G., Xia, F., Mudie, N., & Wu, Y. (2016). maintenance erlotinib versus erlotinib at disease progression in patients with advanced non-small-cell lung cancer who have not progressed following platinum-based chemotherapy (IUNO study). Lung cancer, 102, 30–37. http://access.bl.uk/ark:/81055/vdc_100054580789.0x00004a